Jennifer Specht, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Lyell Immunopharma Inc
    Topic:
    Consultant
    Date added:
    11/21/2023
    Date updated:
    02/27/2024
    Relationship end date:
    09/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Lyell Immunopharma
    Topic:
    Institutional Research
    Date added:
    11/21/2023
    Date updated:
    02/27/2024
    Relationship end date:
    10/05/2026
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Carisma Therapeutics
    Topic:
    Institutional Research
    Date added:
    11/21/2023
    Date updated:
    02/27/2024
    Relationship end date:
    12/31/2026
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Topic:
    Institutional Research
    Date added:
    11/21/2023
    Date updated:
    02/27/2024
    Relationship end date:
    10/18/2024

Pages

Return to 2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility